World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
83
Citations
26824
World Ranking
1434
National Ranking
729

Medicine

D-Index
83
Citations
26824
World Ranking
15549
National Ranking
7836

Overview

Richard T. Davey is affiliated with the National Institute of Allergy and Infectious Diseases in the United States. Their research primarily focuses on the field of Medicine, with a significant number of publications in Infectious Diseases. Subfields of study include Epidemiology, Neurology, Immunology, and Emergency Medical Services.

The scientist's research topics involve a range of areas related to viral infections and immune response. These topics include:

  • COVID-19 Clinical Research Studies
  • Viral Infections and Outbreaks Research
  • SARS-CoV-2 and COVID-19 Research
  • Hepatitis B Virus Studies
  • Long-Term Effects of COVID-19
  • Disaster Response and Management
  • Viral Infections and Vectors

Richard T. Davey has contributed to several recent publications, mostly centered around COVID-19 and related viral infections. Notable papers include:

  • "Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19," 2020, published in New England Journal of Medicine
  • "Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019," 2020, published in The Journal of Infectious Diseases
  • "Detection of Nucleocapsid Antibody to SARS-CoV-2 is More Sensitive than Antibody to Spike Protein in COVID-19 Patients," 2020, published in bioRxiv (Cold Spring Harbor Laboratory)
  • "Fostamatinib Inhibits Neutrophils Extracellular Traps Induced by COVID-19 Patient Plasma: A Potential Therapeutic," 2020, published in The Journal of Infectious Diseases
  • "Fostamatinib for the Treatment of Hospitalized Adults With Coronavirus Disease 2019: A Randomized Trial," 2021, published in Clinical Infectious Diseases

Their frequent co-authors have included:

  • Daniel S. Chertow
  • Jeffrey R. Strich
  • Aneesh K. Mehta
  • Cameron R. Wolfe
  • Nadine Rouphael

Research outputs have been published across several venues, with a concentration in journals focused on infectious diseases and clinical medicine. Frequent publication venues include:

  • The Journal of Infectious Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Annals of Internal Medicine
  • New England Journal of Medicine
  • Clinical Infectious Diseases

Best Publications

  • Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.

    Andre C Kalil;Thomas F Patterson;Aneesh K Mehta;Kay M Tomashek

  • A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics.

    Mulangu S;Dodd Le;Davey Rt;Tshiani Mbaya O

  • HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

    Richard T. Davey;Niranjan Bhat;Christian Yoder;Tae Wook Chun

  • Persisting Illness and Fatigue in Adults with Evidence of Epstein-Barr Virus Infection

    S E Straus;G Tosato;G Armstrong;T Lawley

  • CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection.

    H Masur;F P Ognibene;R Yarchoan;J H Shelhamer

  • Multiple, Linked Human Immunodeficiency Virus Type 1 Drug Resistance Mutations in Treatment-Experienced Patients Are Missed by Standard Genotype Analysis

    Sarah Palmer;Mary Kearney;Frank Maldarelli;Elias K. Halvas

  • A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection.

    Davey Rt;Dodd L;Proschan Ma

  • Re-emergence of HIV after stopping therapy

    T W Chun;R T Davey;D Engel;H C Lane

  • Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus.

    Joseph A. Kovacs;Susan Vogel;Jeffrey M. Albert;Judith Falloon

  • Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy.

    Tae Wook Chun;Richard T. Davey;Mario Ostrowski;J. Shawn Justement

  • Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy.

    Chun Tw;Engel D;Mizell Sb;Hallahan Cw

  • Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study.

    J A Kovacs;M Baseler;R J Dewar;S Vogel

  • A Recombinant Vesicular Stomatitis Virus Ebola Vaccine — Preliminary Report

    Jason A. Regules;John H. Beigel;Kristopher M. Paolino;Jocelyn Voell

  • Clinical Management of Ebola Virus Disease in the United States and Europe.

    Timothy M. Uyeki;Aneesh K. Mehta;Richard T. Davey;Allison M. Liddell

  • A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS

    A G Palestine;M A Polis;M D De Smet;B F Baird

  • ART Suppresses Plasma HIV-1 RNA to a Stable Set Point Predicted by Pretherapy Viremia

    Frank Maldarelli;Sarah Palmer;Martin S King;Ann Wiegand

  • Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge Model

    Matthew J. Memoli;Pamela A. Shaw;Alison Han;Lindsay Czajkowski

  • Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019.

    Peter D Burbelo;Francis X Riedo;Chihiro Morishima;Stephen Rawlings

  • Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection.

    Robert E. Walker;Christine M. Bechtel;Ven Natarajan;Michael Baseler

  • High-level HIV-1 viremia suppresses viral antigen-specific CD4+ T cell proliferation

    McNeil Ac;Shupert Wl;Iyasere Ca;Hallahan Cw

  • Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial.

    H. Clifford Lane;Victoria Davey;Joseph A. Kovacs;Judith Feinberg

  • Evidence for increased T cell turnover and decreased thymic output in HIV infection.

    Daniel C. Douek;Michael R. Betts;Brenna J. Hill;Susan J. Little

Frequent Co-Authors

Julia A. Metcalf
Julia A. Metcalf National Institute of Allergy and Infectious Diseases
H. Clifford Lane
H. Clifford Lane National Institute of Allergy and Infectious Diseases
Joseph A. Kovacs
Joseph A. Kovacs National Institutes of Health
Michael A. Polis
Michael A. Polis National Institute of Allergy and Infectious Diseases
Henry Masur
Henry Masur National Institutes of Health
Michael Baseler
Michael Baseler Leidos (United States)
Anthony S. Fauci
Anthony S. Fauci Georgetown University
Irini Sereti
Irini Sereti National Institutes of Health
Claire W. Hallahan
Claire W. Hallahan National Institute of Allergy and Infectious Diseases
Timothy M. Uyeki
Timothy M. Uyeki Centers for Disease Control and Prevention

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in studying immunology in the USA, exploring related healthcare degrees can open diverse career pathways. Many students transition into healthcare roles that complement immunology, such as nursing or specialized clinical practice.

Accelerated nursing programs offer fast-tracked options for individuals without a nursing background. If you’re looking to shift careers, consider accelerated BSN programs for non nurses that provide streamlined admission processes.

LPN programs also serve as an accessible entry point into healthcare. Those exploring practical nursing can find accredited LPN programs easy to get into, helping them build foundational skills needed in clinical and laboratory settings related to immunology.

For advanced practice, nurse practitioner programs with easy admission can help you quickly gain qualifications to engage with patient care and disease management, key areas tied to immunological health.

Lastly, if you have a passion for mental health alongside immunology, consider PMHNP programs online with best clinical placement. These programs ensure strong hands-on experience while accommodating flexible learning schedules.

Best Scientists Citing Richard T. Davey

Trending Scientists